Barclays has lowered its price target on The Mosaic Company (MOS) to $31 from $35, maintaining an Overweight rating. JPMorgan also reduced its target price to $24 from $26, suggesting investors look at Nutrien or Corteva. 19 Wall Street analysts rate MOS as a Moderate Buy, with an average price target of $34.01, indicating a 43% upside potential. The company declared a quarterly dividend of $0.22 per share, payable on December 18, 2025. The Mosaic Company (MOS) produces concentrated phosphate and potash crop nutrients, down 3% year-to-date.

Read more at Yahoo Finance: Barclays Lowers Price Target on The Mosaic Company (MOS) to $31, Maintains Overweight Rating